A detailed analysis of the effect of repetitive transcranial magnetic stimulation on negative symptoms of schizophrenia: A double-blind trial

Schizophrenia Research

Volumn 149, Issue 1-3, 2013, Pages 167-173

  Prikryl, Radovan ^a,b   Ustohal, Libor ^a,b   Prikrylova Kucerova, Hana ^a,b   Kasparek, Tomas ^a,b   Venclikova, Simona ^a,b   Vrzalova, Michaela ^a,b   Ceskova, Eva ^a,b  

^a MASARYK UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

High frequency; Negative symptoms; Prefrontal cortex; Repetitive transcranial magnetic stimulation; rTMS; SANS

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CLOZAPINE; HALOPERIDOL; LAMOTRIGINE; OLANZAPINE; PALIPERIDONE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ADULT; ALOGIA; ANHEDONIA; APATHY; ARTICLE; ATTENTION DISTURBANCE; BLUNTED AFFECT; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; HUMAN; MALE; NEGATIVE SYNDROME; OUTCOME ASSESSMENT; PREFRONTAL CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; SCHIZOPHRENIA; SYMPTOMATOLOGY; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

HIGH-FREQUENCY; NEGATIVE SYMPTOMS; PREFRONTAL CORTEX; REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; RTMS; SANS;

ADULT; ANALYSIS OF VARIANCE; DOUBLE-BLIND METHOD; ELECTROMYOGRAPHY; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84881258154     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.06.015     Document Type: Article

References (40)

1. Addington D., Addington J., Schissel B. A depression rating scale for schizophrenics. Schizophr. Res. 1990, 3:247-251.
2. Andreasen N.C. Negative symptoms in schizophrenia. Definition and reliability. Arch. Gen. Psychiatry 1982, 39:784-788.
3. Andreasen N.C. Scale for the Assessment of Positive Symptoms (SAPS) 1984, University of Iowa, Iowa City, IA.
4. Andreasen N.C. The evolving concept of schizophrenia: from Kraepelin to the present and future. Schizophr. Res. 1997, 28:105-109.
5. Andreasen N.C., Kezai K., Alliger R., et al. Hypofrontality in neuroleptic naive patients and in patients with chronic schizophrenia. Arch. Gen. Psychiatry 1992, 26:14-16.
6. Arana A.B., Borckardt J.J., Ricci R., et al. Electrical Stimulation as a sham control for rTMS: does it truly mimic the cutaneous sensation and pain of active prefrontal rTMS?. Brain Stimul. 2008, 1:4-51.
7. Barr M.S., Tarzan F., Tran L.C., Fitzgerald P.B., Daskalakis Z.J. A randomized controlled trial of sequentially bilateral prefrontal cortex repetitive transcranial magnetic stimulation in the treatment of negative symptoms in schizophrenia. Brain Stimul. 2012, 5:337-346.
8. 2 receptor characteristics in rat brain. Brain Res. 1999, 816:78-83.
9. Borckardt J., Walker J., Branham R.K., et al. Development and evaluation of a portable sham tms system. Brain Stimul. 2008, 1:52-59.
10. Bow-Thomas C.C., Velligan D.I., Miller A.L., et al. Predicting quality of life from symptomatology in schizophrenia at exacerbation and stabilization. Psychiatry Res. 1999, 86:131-142.
11. Buchanan R.W., Breier A., Kirkpatrick B., et al. Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome. Am. J. Psychiatry 1998, 155:751-760.
12. Dickerson F., Boronow J.J., Ringel N., et al. Social functioning and neurocognitive deficits in outpatients with schizophrenia: a 2year follow-up. Schizophr. Res. 1999, 37:13-20.
13. Dlabac-de Lange J.J., Knegtering R., Aleman A. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: review and meta-analysis. J. Clin. Psychiatry 2010, 71:411-419.
14. Erhart S.M., Marder S.R., Carpenter W.M. Treatment of schizophrenia negative symptoms: future prospects. Schizophr. Bull. 2006, 32:234-237.
15. Freitas C., Fregni F., Pascual-Leon A. Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia. Schizophr. Res. 2009, 108:11-24.
16. Goyal N., Nizamie S.H., Desarkar P. Efficacy of adjuvant high frequency repetitive transcranial magnetic stimulation on negative and positive symptoms of schizophrenia: preliminary results of a double blind sham-controlled study. J. Neuropsychiatry Clin. Neurosci. 2007, 19:464-467.
17. Hajak G., Marienhagen J., Langguth B., et al. High-frequency repetitive transcranial magnetic stimulation in schizophrenia: a combined treatment and neuroimaging study. Psychol. Med. 2004, 34:1157-1163.
18. Herwig U., Padberg F., Unger J., et al. Transcranial magnetic stimulation in therapy studies: examination of the reliability of "standard" coil positioning by neuronavigation. Biol. Psychiatry 2001, 50:58-61.
19. Hoffman R., Buchsbaum M., Escobar M., et al. EEG coherence of prefrontal areas in normal and schizophrenia males during perceptual activation. J. Neuropsychiatry Clin. Neurosci. 1991, 3:169-175.
20. Jin Y., Potkin S.G., Kemp A.S., et al. Therapeutic effects of individualized frequency transcranial magnetic stimulation (rTMS) on the negative symptoms of schizophrenia. Schizophr. Bull. 2006, 32:556-561.
21. 1A and NMDA binding sites by a single rapid transcranial magnetic stimulation procedure in rats. Brain Res. 1999, 826:309-312.
22. Lecrubier Y., Quintin P., Bouhassira M., et al. The treatment of negative symptoms and deficit states of chronic schizophrenia: olanzapine compared to amisulpride and placebo in a 6month double blind controlled clinical trial. Acta Psychiatr. Scand. 2006, 114:319-327.
23. Leucht S., Corves C., Arbter D., et al. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009, 3:31-41.
24. Matheson S.L., Green M.J., Loo C., Carr V.J. Quality assessment and comparison of evidence for electroconvulsive therapy and repetitive transcranial magnetic stimulation for schizophrenia: a systematic meta-review. Schizophr. Res. 2010, 118:201-210.
25. Milev P., Ho B.C., Arndt S., et al. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudional first-episode study with 7-year follow-up. Am I Psychiatry 2005, 162:495-506.
26. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 1979, 134:382-389.
27. Nahas Z., Teneback C.C., Kozel A., et al. Could left prefrontal rTMS modify negative symptoms and attention in schizophrenia?. Biol. Psychiatry 1999, 45(Suppl.1):37.
28. Prikryl R., Kasparek T., Skotakova S., et al. Treatment of negative symptoms of schizophrenia using repetitive transcranial magnetic stimulation in a double-blind, randomized controlled study. Schizophr. Res. 2007, 95:151-157.
29. Ragert P., Dinse H.R., Pleger B., et al. Combination of 5Hz repetitive transcranial magnetic stimulation (rTMS) and tactile coactivation boosts tactile discrimination in humans. Neurosci. Lett. 2003, 348:105-108.
30. Rollnik J.D., Huber T.J., Mogg H., et al. High frequency repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex in schizophrenic patients. Neuroreport 2000, 11:4013-4015.
31. Sachdev P., Loo C., Mitchell P., et al. Transcranial magnetic stimulation for the deficit syndrome of schizophrenia: a pilot investigation. Psychiatry Clin. Neurosci. 2005, 59:354-357.
32. Salzman C.D., Fusi S. Emotion, cognition, and mental state representation in amygdala and prefrontal cortex. Annu. Rev. Neurosci. 2010, 33:173-202.
33. Sanfilipo M., Lafargue T., Rusinek H., et al. Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms. Arch. Gen. Psychiatry 2000, 57:471-480.
34. Schneider A.L., Schneider T.L., Stark H. Repetitive transcranial magnetic stimulation (rTMS) as an augmentation treatment for the negative symptoms of schizophrenia: a 4-week randomized placebo controlled study. Brain Stimul. 2008, 1:106-111.
35. Sheehan D.V., Lecrubier Y., Sheehan K.H., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59:22-33.
36. Spicer K.M., Arana G., Bohning D.E., et al. Brain effects of TMS delivered over prefrontal cortex in depressed adults: role of stimulation frequency and coil-cortex distance. J. Neuropsychiatry Clin. Neurosci. 2001, 13:459-470.
37. StatSoft, Inc. STATISTICA (data analysis software system), version 10 http://www.statsoft.com.
38. Strafella A.P., Paus T., Barrett J., et al. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J. Neurosci. 2001, 1:RC157.
39. Taber M.T., Fibiger H.C. Electrical stimulation of the prefrontal cortex increases dopamine release in the nucleus accumbens of the rat: modulation by metabotropic glutamate receptors. J. Neurosci. 1995, 15:3896-3904.
40. Tollefson G., Bealey C., Tran P., et al. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. Am. J. Psychiatry 1997, 154:457-474.